About 100 reports

  • PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF DIARRHEA TO GASTROINTESTINAL CLINICAL...
  • Gastrointestinal Drug
  • Opioid
  • Pharmaceutical
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 1039 Trial Title
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Official Title
  • Clinical Trial profile. 35 Trial Title
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trials by E7 Countries: Proportion of Constipation to Gastrointestinal Clinical...
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CONSTIPATION TO GASTROINTESTINAL CLINICAL...
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Braintree Laboratories Inc.
  • GI INFLAMMATION VIA A CYCLIC GMP MEDIATED MECHANISM TO DOWNREGULATE IKK AND NF-KAPPAB."
  • Opioid-Induced Constipation (OIC) - Pipeline by Theravance Biopharma Inc, H2 2017

These medicines affect the gastrointestinal tract in a variety of ways.

  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 177 Trial Title
  • Clinical Trial profile. 99 Trial Title

PROPORTION OF DUODENAL ULCER TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF DUODENAL ULCER TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* In total there were ## clinical trials conducted on Duodenal Ulcer, as of July 2017 in G## Countries, o

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 242 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Yt Blood Group
  • Clinical Trial profile. 17 Trial Title
  • Target

PROPORTION OF BARRETTS ESOPHAGUS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF BARRETTS ESOPHAGUS TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* AS OF APRIL 2017, THERE WERE ## CLINICAL TRIALS IN PHASE II, OF WHICH THREE CLINICAL TRIALS WE

  • Gastrointestinal Drug
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 157 Trial Title
  • Official Title
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Yt Blood Group
  • Target
  • Clinical Trial profile. 21 Trial Title
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Bayer AG
  • Clinical Trial profile. 91 Trial Title
  • Clinical Trial profile. 15 Trial Title

PROPORTION OF CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* PROPORTION OF CORROSIVE ESOPHAGITIS (EROSIVE ESOPHAGITIS) TO GASTROINTESTINAL CLINICAL TRIALS, G## COUNTRIES (%), 2017* In total there were ## clinical trials condu

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Takeda Pharmaceutical Company Limited
  • Clinical Trial profile. 38 Trial Title
  • FECAL INCONTINENCE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT...

PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2017* PROPORTION OF FECAL INCONTINENCE TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • RDD Pharma
  • Clinical Trials by G7 Countries: Proportion of Constipation to Gastrointestinal Clinical...
  • Proportion of Constipation to Gastrointestinal Clinical Trials, E7 Countries (%),...
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 171 Trial Title
  • Clinical Trial profile. 301 Trial Title
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC
  • Legal Advisor
  • Deal Rationale

Evoke Pharma Inc (Evoke Pharma) is a specialty pharmaceutical company that develops drugs to treat gastrointestinal diseases.

  • Gastrointestinal Drug
  • United States
  • Company Operations
  • Product Initiative
  • Evoke Pharma, Inc.
  • Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis...
  • Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis...
  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES
  • Dec 09, 2014: RedHill Biopharma Submits BEKINDA (RHB-102) European Marketing Authorization...

IBS is one of the most common gastrointestinal disorders.

  • Gastrointestinal Drug
  • United States
  • World
  • Product Initiative
  • RedHill Biopharma Ltd.
  • Deal Type
  • Deal Type

Its products portfolio includes antibiotics, infusions, containing amino acid, vitamin and hepatic protect infusions; gastrointestinal agents, comprising of digestives and antiulcerants.

  • Gastrointestinal Drug
  • South Korea
  • Company
  • M&A
  • Biopharmaceuticals Inc.
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries...
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries...
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • DIARRHEA - PIPELINE BY RXBIO INC, H1 2017
  • DIARRHEA - PIPELINE BY REDHILL BIOPHARMA LTD, H1 2017

Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 121 Trial Title
  • Official Title

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Zollinger-Ellison Syndrome (Gastrinoma

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Hospital
  • World
  • Product Initiative
  • Clinical Trial profile. 64 Trial Title
  • Clinical Trial profile. 353 Trial Title
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Clinical Trial profile. 19 Trial Title
  • Clinical Trial profile. 13 Trial Title
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Bayer AG
  • DA-6886 - DRUG PROFILE
  • Constipation - Drug Profiles

These agents also stimulate motility throughout the gastrointestinal tract.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Clinical Trial profile. 211 Trial Title
  • Clinical Trial profile. 32 Trial Title
  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Target
  • Clinical Trial profile. 23 Trial Title

Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Nonerosive Reflux Disease (NERD) to Gastrointestinal Clinical Trials, E## Countries (%), 2016* Proportion of Nonerosive Reflux Disease (NERD) to

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • PARTNERSHIPS
  • Company Overview

Synergy Pharmaceuticals Inc (Synergy Pharma) develops therapies for gastrointestinal (GI) diseases.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synergy Pharmaceuticals, Inc.
  • EQUITY OFFERING

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Sucampo Pharmaceuticals, Inc.
  • Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis...
  • Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis...
  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES

Gastrointestinal ulcers and gastric motility disorders are common in China and have a significant patient base.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Litigation And Patent
  • AstraZeneca PLC